Michelle Martinot Peignoux

Summary

Country: France

Publications

  1. ncbi Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
    Michelle Martinot-Peignoux
    Unité de Recherche INSERM U 481, Centre de Recherche Claude Bernard sur les Hépatites Virales and Service d Hépatologie, Hopital Beaujon, 100 Boulevard du General Leclerc, 92110 Clichy, France
    J Hepatol 36:543-6. 2002
  2. ncbi A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C
    M Martinot-Peignoux
    Unité de Recherche INSERM U481, Hopital Beaujon, Clichy, France
    Hepatology 31:726-9. 2000
  3. ncbi Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays
    M Martinot-Peignoux
    Unité de Recherche INSERM U481, Centre de Recherche Claude Bernard sur les Hépatites Virales and Service d Hépatologie, Hopital Beaujon, 92110 Clichy, France
    J Clin Microbiol 38:2722-5. 2000
  4. ncbi Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
    M Martinot-Peignoux
    Unité de Recherche INSERM U481, Centre de Recherche Claude Bernard sur les Hépatites Virales and Service d Hépatologie, Hopital Beaujon, Clichy, France
    Hepatology 34:1000-5. 2001
  5. ncbi Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C
    M Martinot-Peignoux
    INSERM U481, Service d Hepatologie, Hopital Beaujon, Clichy, France
    J Viral Hepat 13:701-7. 2006
  6. ncbi Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C
    Sarah Maylin
    Universite Paris VII, Hopital Beaujon, Clichy, France
    Gastroenterology 135:821-9. 2008
  7. ncbi Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
    Rami Moucari
    Service d Hepatologie, Hopital Beaujon, Clichy, France
    Hepatology 49:1151-7. 2009
  8. ncbi Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue
    Tarik Asselah
    Service d Hépatologie and Institut National de la Santé et de la Recherche Médicale INSERM U733, CRB3, Universite Paris Diderot, Assistance Publique Hopitaux de Paris, Hopital Beaujon, Clichy, France
    Hepatology 48:953-62. 2008
  9. ncbi Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapy
    Manuela G Neuman
    Division of Clinical Pharmacology E-240, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
    Rom J Gastroenterol 11:97-103. 2002
  10. ncbi Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response
    Dan Avi Landau
    Universite Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Assistance Publique Hopitaux de Paris, Hopital Pitie Salpetriere, Paris, France
    Arthritis Rheum 58:604-11. 2008

Collaborators

  • Tarik Asselah
  • Patrick Marcellin
  • B N Pham
  • L Comanor
  • Dominique Charles Valla
  • Valerie Paradis
  • P Bedossa
  • P Halfon
  • Patrice P Cacoub
  • Manuela G Neuman
  • Ivan Bieche
  • Michelle Martinot-Peignoux
  • M Martinot-Peignoux
  • Corinne Castelnau
  • Nathalie Boyer
  • Rami Moucari
  • Sarah Maylin
  • Marie Pierre Ripault
  • N Boyer
  • Marie Hélène Nicolas-Chanoine
  • Dan Avi Landau
  • Marie-Pierre Ripault
  • V Le Breton
  • C Castelnau
  • G Le Guludec
  • Vincent Mackiewicz
  • Agnes Dauvergne
  • Olivier Lada
  • Michel Vidaud
  • Dan-Avi Landau
  • David Saadoun
  • Elena Fois
  • Dominique Cazals-Hatem
  • Cyrille Feray
  • Nathalie Giuily
  • Ana Carolina Cardoso
  • Emmanuel Gordien
  • J M Minor
  • D Hendricks
  • N Giuily
  • Elyanne Gault
  • M P Ripault
  • Rahouda Akremi
  • Magalie Colombat
  • Claude Degott
  • Stephan Ollivier
  • A Gervais
  • S Levy
  • D Cazals-Hatem
  • C Degott
  • R Akremi
  • N Labouret
  • S Fritsch
  • F Keller

Detail Information

Publications12

  1. ncbi Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
    Michelle Martinot-Peignoux
    Unité de Recherche INSERM U 481, Centre de Recherche Claude Bernard sur les Hépatites Virales and Service d Hépatologie, Hopital Beaujon, 100 Boulevard du General Leclerc, 92110 Clichy, France
    J Hepatol 36:543-6. 2002
    ..The new definition inactive surface antigen (HBsAg) carriers includes an estimated serum HBV DNA level below 105 copies/ml. However, this cut-off value needs to be confirmed...
  2. ncbi A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C
    M Martinot-Peignoux
    Unité de Recherche INSERM U481, Hopital Beaujon, Clichy, France
    Hepatology 31:726-9. 2000
    ....
  3. ncbi Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays
    M Martinot-Peignoux
    Unité de Recherche INSERM U481, Centre de Recherche Claude Bernard sur les Hépatites Virales and Service d Hépatologie, Hopital Beaujon, 92110 Clichy, France
    J Clin Microbiol 38:2722-5. 2000
    ..Our results indicate that COBAS HCV MONITOR version 2.0 and QUANTIPLEX HCV RNA version 2.0 assays showing an equal dynamic range for each HCV genotype are suitable tools to assess patients before therapy...
  4. ncbi Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
    M Martinot-Peignoux
    Unité de Recherche INSERM U481, Centre de Recherche Claude Bernard sur les Hépatites Virales and Service d Hépatologie, Hopital Beaujon, Clichy, France
    Hepatology 34:1000-5. 2001
    ..During follow-up, the HCV RNA status of patients remained unchanged; 21% of the patients with detectable serum HCV RNA had slight increase in serum ALT levels, but histological lesions remained stable...
  5. ncbi Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C
    M Martinot-Peignoux
    INSERM U481, Service d Hepatologie, Hopital Beaujon, Clichy, France
    J Viral Hepat 13:701-7. 2006
    ..A week 4 stopping rule for patients with chronic hepatitis C treated with peginterferon with ribavirin might be proposed by using the model developed in our study...
  6. ncbi Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C
    Sarah Maylin
    Universite Paris VII, Hopital Beaujon, Clichy, France
    Gastroenterology 135:821-9. 2008
    ..It is unclear whether hepatitis C virus (HCV) is eradicated in patients with chronic hepatitis C who achieved a sustained virologic response (SVR)...
  7. ncbi Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
    Rami Moucari
    Service d Hepatologie, Hopital Beaujon, Clichy, France
    Hepatology 49:1151-7. 2009
    ..CONCLUSION: Early serum HBsAg drop has high predictive values of SVR to PEG-IFN in HBeAg-negative CHB patients. Serum quantitative HBsAg may be a useful tool to optimize the management of PEG-IFN therapy in these patients...
  8. ncbi Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue
    Tarik Asselah
    Service d Hépatologie and Institut National de la Santé et de la Recherche Médicale INSERM U733, CRB3, Universite Paris Diderot, Assistance Publique Hopitaux de Paris, Hopital Beaujon, Clichy, France
    Hepatology 48:953-62. 2008
    ....
  9. ncbi Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapy
    Manuela G Neuman
    Division of Clinical Pharmacology E-240, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
    Rom J Gastroenterol 11:97-103. 2002
    ..In addition, it is able to reduce fibrosis as judged both by TGF-beta levels and fibrosis scores as compared to standard therapy...
  10. ncbi Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response
    Dan Avi Landau
    Universite Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Assistance Publique Hopitaux de Paris, Hopital Pitie Salpetriere, Paris, France
    Arthritis Rheum 58:604-11. 2008
    ....
  11. ncbi Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy
    Manuela G Neuman
    Division of Clinical Pharmacology, E 240, Sunnybrook and Women s College Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
    Cytokine 17:108-17. 2002
    ....
  12. ncbi Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up
    Corinne Castelnau
    , , AP-HP; INSERM U773 CRB3, Clichy, , Bobigny, France
    Hepatology 44:728-35. 2006
    ..The follow-up of HDV-RNA levels during therapy, which allows the differentiation of various profiles of virological responses, improves treatment monitoring...